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1637VSD is the second most common defect in trisomy-
21 after complete atrioventricular septal defect. Irving
and Chaudhari (2) showed in their study, on the basis
of a population registry, that among 821 infants born
with Down syndrome, 31% had VSD. The short life
expectancy in patients with Down syndrome can be
related to other noncardiac causes. Uppal et al. (3)
showed that respiratory-related comorbidities and
dementia are among the leading causes of mortality
in Down syndrome. In our study of interest (1), sur-
vival rates were compared with the expected survival
rates of an age-matched Dutch population. Informa-
tion on the prevalence of trisomy-21 in both groups
was not provided. Although the cumulative survival
rate was only slightly lower than the general Dutch
population after excluding early post-operative mor-
tality, comparing the study cohort with a matching
group with similar prevalence of trisomy-21 will
result in more accurate cumulative survival rates.*Fady Y. Marmoush, MD
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Ventricular Septal DefectWe thank Dr. Marmoush and colleagues for their
response to our paper (1) describing the survival and
clinical outcome in patients up to 40 years after sur-
gical closure of a ventricular septal defect (VSD).
Dr. Marmoush and colleagues justly remarked the
high incidence of VSD in infants with Down syn-
drome. Patients with Down syndrome have a shorter
life expectancy than the general population (2). In
our study, we used survival rates of an age-matchedDutch population, which were on the basis of all
Dutch residents, including patients with Down syn-
drome. In the 1980s, the estimated incidence of Down
syndrome among newborns in the Netherlands was 10
to 14 per 10,000 live births (3). In our study cohort
consisting of 174 patients with VSD, none had Down
syndrome, even though Down syndrome was not an
exclusion criterion. This could probably be explained
by the fact that in this early surgical era heart de-
fects were not always surgically repaired in patients
with Down syndrome and by the relatively small
number of included patients. Therefore, we think
that, regarding the prevalence of Down syndrome, it
was justiﬁed to compare the survival rates of our
study cohort with those of the normal Dutch popu-
lation. However, 8 patients with other syndromic,
chromosomal, or psychomotor abnormalities partici-
pated in our study: psychomotor retardation (n ¼ 3),
22q11 deletion (n ¼ 2 of whom 1 deceased), VACTERL
(Vertebral anomalies, Anal atresia, Cardiac defects,
Tracheoesophageal ﬁstula and/or Esophageal atresia,
Renal & Radial anomalies and Limb defects) associa-
tion (n ¼ 1), Holt-Oram syndrome (n ¼ 1), and he-
reditary motor and sensory neuropathy (n ¼ 1).
The mortality in this subgroup of patients with a
syndrome is comparable with the mortality in our
complete cohort (i.e., 31 deceased patients out of the
156 traceable patients). In conclusion, we agree that
syndromic or chromosomal abnormalities can affect
survival rates in general, but this does not affect the
results in our study.Myrthe E. Menting, MD
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